Xponance Inc. Grows Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Xponance Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 6.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,454 shares of the biopharmaceutical company’s stock after buying an additional 1,051 shares during the quarter. […]
Xponance Inc. raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 6.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,454 shares of the biopharmaceutical company’s stock after buying an additional 1,051 shares during the quarter. […]
